Dr. Kittai is an Associate Professor at the Icahn School of Medicine at Mount Sinai in New York, NY where he is the Assistant Director of Lymphoma Clinical Research and CLL Clinical Research Leader. His clinical and research focus is on Chronic Lymphocytic Leukemia, Richter Transformation and related disorders. He is the primary investigator of multiple investigator-initiated trials exploring the use of small molecule inhibitors with novel designs and deploying cellular therapies for CLL and Richter transformation. Dr. Kittai is also interested in re-defining prognostic features for patients with CLL in the era of targeted therapies, as well as defining and mitigating racial disparities that exist in CLL. He is the recipient of the American Society of Clinical Oncology Career Development Award which funds his time for research, is an active member of the Committee on Training for the American Society of Hematology.